A rare occurrence of Serratia rubidaea in a patient with ear discharge

Vimal Kumar Karnaker1, Asem Ali Ashraf1, Sreelatha Shankaran Veetil2

  • 1Department of Microbiology, KS Hegde Medical Academy (KSHEMA), Nitte (Deemed to be University), Mangalore, Karnataka, India.

Insights

Serratia rubidaea, a rare bacterium, was identified in ear discharge from a patient with chronic otomastoiditis. This case highlights its potential role in infections following invasive procedures.

Area of Science:

  • Microbiology
  • Clinical Medicine
  • Infectious Diseases

Background:

  • Serratia species, part of the Enterobacteriaceae family, are infrequently implicated in human infections compared to more virulent strains.
  • While Serratia marcescens is the most common species causing infections, approximately 10 Serratia species are recognized, with others rarely reported in clinical settings.
  • Infections due to less common Serratia species are seldom documented, often due to their infrequent isolation from patient samples.

Observation:

  • This report details a case of Serratia rubidaea isolated from the ear discharge of a 35-year-old female patient.
  • The patient presented with a history of chronic otomastoiditis and had previously undergone a left modified radical mastoidectomy.
  • Notably, the patient had no other significant co-morbidities.

Findings:

  • The isolation of Serratia rubidaea from clinical specimens, such as ear discharge, is considered rare.
  • This finding suggests that Serratia rubidaea can act as an etiological agent in post-operative or invasive procedure-related infections.
  • The patient received antibiotic treatment for the infection.

Implications:

  • This case underscores the importance of considering less common Serratia species in the differential diagnosis of infections, particularly in patients with a history of invasive procedures.
  • Recognizing Serratia rubidaea as a potential pathogen can guide appropriate antimicrobial therapy and improve patient outcomes.
  • Further surveillance and case reporting are needed to fully understand the clinical significance and pathogenic potential of rare Serratia species.